However, berberine did improve sugar and cholesterol
When Zepbound is covered, prior authorization is usually required, and the patient may need to meet clinical requirements such as a BMI of 30 or more or a BMI of 27 or more with a comorbid condition like hypertension or Type 2 diabetes, and documented weight management efforts like a low-calorie diet and increased physical activity
Additionally, the limited supply of many of these products has increasingly shifted toward use in obesity treatment, driven by profit motives, leaving many type 2 diabetes patients unable to access medications they rely upon
The global GLP-1 receptor agonist market is rapidly expanding due to the rising prevalence of type 2 diabetes and obesity, which have become major public health concerns
Short-acting GLP-1 receptor agonists include immediate-release exenatide (Byetta) with a half-life of approximately 2.4 hours
The evidence base here is predominantly preclinical and anecdotal for fat loss specifically